Status:
NOT_YET_RECRUITING
Determination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents Versus Biolimus A9-eluting Stents
Lead Sponsor:
Yonsei University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20+ years
Brief Summary
This study is a retrospective and prospective follow-up study of patients who were participating in a randomized comparative study (DETECT-OCT trial) to determine the duration of dual antiplatelet the...
Detailed Description
This clinical trial will be followed for a long time until the 5th and 10th years of patients who have been registered for the DETECT-OCT study To assess the patient's status at 5- and 10-year, follow...
Eligibility Criteria
Inclusion
- 1\. patients who were enrolled in the previous DETECT-OCT study
- 2\. Patients who agreed with informed consents
Exclusion
- 1\. Patients who disagreed with informed consents
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
894 Patients enrolled
Trial Details
Trial ID
NCT03873012
Start Date
April 1 2019
End Date
April 1 2027
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine
Seoul, South Korea, 120-752